Rubric Capital Management is a venture debt provider. The known portfolio counts 6 companies, including Edesa Biotech, Heron Therapeutics, Mereo Biopharma, Trevi Therapeutics, Karyopharm Therapeutics and TherapeuticsMD.
Is Rubric Capital Management a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Late-Stage
Contacts
Rubric Capital Management portfolio companies (6)
- Edesa Biotech
- Heron Therapeutics
- Mereo Biopharma
- Trevi Therapeutics
- Karyopharm Therapeutics
- TherapeuticsMD
Co-investors
Funds that share portfolio companies with Rubric Capital Management.
Similar funds
Showing 20 of 100
About Rubric Capital Management
The firm's known deals cluster at Late-Stage.
Rubric Capital Management shares portfolio companies with 9 other investment firms, among them Broadfin Capital, Multiple Myeloma Research Foundation and Tang Capital Management.
Frequently asked questions
What is Rubric Capital Management?
Rubric Capital Management is a venture debt provider with a known portfolio of 6 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What stage does Rubric Capital Management invest at?
The known deals of Rubric Capital Management include Late-Stage rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
How do I contact Rubric Capital Management?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal